Viridian Therapeutics, Inc.\DE
SEC CIK 1590750 · VRDN · last insider filing 2026-05-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Fairmount Healthcare Fund II L.P. | Director | filed 2020 - 2026 |
| Fairmount Funds Management LLC | Director | filed 2020 - 2026 |
| Fairmount Healthcare Fund II GP LLC | Director | filed 2020 - 2026 |
| Mahoney Stephen F. | Director · President and CEO | filed 2023 - 2026 |
| Morris Arlene | Director | filed 2018 - 2025 |
| Ajer Jeffrey Robert | Director | filed 2025 - 2025 |
| Moses Jennifer K. | Director | filed 2021 - 2025 |
| Cain Christopher W. | Director | filed 2025 - 2025 |
| Kiselak Tomas | Director | filed 2020 - 2025 |
| Gheuens Sarah | Director | filed 2023 - 2025 |
| Harwin Peter Evan | Director | filed 2020 - 2024 |
| Fairmount Healthcare Fund L.P. | Director | filed 2020 - 2024 |
| Fairmount Healthcare Fund GP LLC | Director | filed 2020 - 2024 |
| Myers Scott Dunseth | Director · Chief Executive Officer | filed 2023 - 2023 |
| Violin Jonathan | Director · See Remarks | filed 2020 - 2023 |
| Turner Joseph L | Director | filed 2017 - 2021 |
| Hatfield Jeffrey S. | Director | filed 2017 - 2021 |
| Rauch Lee M. | Director · President & CEO | filed 2020 - 2021 |
| Marshall William Stuart | Director · President & CEO | filed 2017 - 2021 |
| Koch Kevin | Director | filed 2017 - 2020 |
| Bowden Christopher | Director | filed 2017 - 2020 |
| Hughes Thomas E. | Director | filed 2017 - 2020 |
| Booth Bruce | Director | filed 2017 - 2018 |
| Lefkoff Kyle | Director | filed 2017 - 2017 |
| Creecy John W | Director | filed 2017 - 2017 |
| Lebow Bennett S | Director | filed 2014 - 2017 |
| Gonyer David A | Director | filed 2014 - 2017 |
| Smith Robin L | Director | filed 2014 - 2017 |
| Riccitelli Samuel D | Director · President and CEO | filed 2014 - 2016 |
| Schuling Douglas A | Director | filed 2014 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Beetham Thomas W. | Chief Operating Officer | filed 2023 - 2026 |
| Harmon Seth | See Remarks | filed 2023 - 2026 |
| Tousignant Jennifer | Chief Legal Officer | filed 2024 - 2026 |
| Tripuraneni Radhika | Chief Medical Officer | filed 2025 - 2026 |
| Ciulla Thomas | Chief Medical Officer | filed 2024 - 2024 |
| Meisner Lara | General Counsel and Secretary | filed 2021 - 2023 |
| Katz Barrett | Chief Medical Officer | filed 2021 - 2023 |
| Humer Kristian | CFO and CBO | filed 2021 - 2023 |
| Melvin Carrie | COO | filed 2022 - 2023 |
| Leverone Jason A. | Chief Financial Officer | filed 2017 - 2021 |
| Escolar Diana | Former Chief Medical Officer | filed 2019 - 2021 |
| Rubin Paul D | EVP, Research & Development | filed 2017 - 2019 |
| Levy Adam Scott | Chief Business Officer | filed 2017 - 2019 |
| Seymour Tamara A | CFO, Secretary, Treasurer | filed 2014 - 2016 |
| Johnson Robert Brian | CFO and CAO | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.